Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-19-019764

Chief Operating Officer sold 2,500 shares at $19.20 ($48,000)

  • Chief Operating Officer acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anicetti Vincent R · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-15 Exercise or conversion : show line 1 in the form +2,500 $2.50 $6,251 21,810 D
2019-07-15 Sale : show line 2 in the form −2,500 $19.20 $48,000 19,310 D
Open-market sales · 2,500 sh · avg $19.20 · $48,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-07-15 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −2,500 47,488 D
Loading xslF345X03/doc4.xml…